A complete guide to trends and leading companies in the Engineering and Research business fields, design, development and technology-based research. Includes market analysis, R&D data and several statistical tables. Nearly 400 in-depth profiles of Engineering and Research firms.

A guide to the trends and leading companies in the engineering, research, design, innovation and development business fields. This book contains most of the data you need on the American Engineering & Research Industry. It includes market analysis, R&D data and several statistical tables and nearly 400 profiles of Engineering and Research firms.

To safeguard the U.S. against animal disease, research has been conducted at the Plum Island Animal Disease Center (PIADC), off the coast of N.Y., on animal diseases not native to the U.S. PIADC is outdated and too limited to continue as the primary facility for this research. A plan to provide safe, secure, and state-of-the-art agriculture bio-containment labs for R&D of diagnostic capabilities and medical counter-measures for foreign animal and zoonotic diseases has been approved. A new facility will be constructed which would house high-containment labs able to handle the pathogens currently under investigation at PIADC, as well as others. Community concerns about safety and security are being voiced about NBAF. This is a print on demand report.

Highly Commended in the Basis of Medicine, 2011 BMA Medical Book Awards. British Medical Association News of financial entanglements among biomedical companies and researchers has increasingly called into question the worth and integrity of medical studies, nearly three-fifths of which are funded by industry. This volume assesses the ethical, quantitative, and qualitative questions posed by the current financing of biomedical research. The ten essays collected here reflect the wide range of opinions about perceived financial conflicts of interest in medical studies. The opening section provides an overview of the issue, describing the origins of, and concerns raised by, dubious financial arrangements; explaining how certain common situations intensify problematic funding structures; weighing the risks and benefits of commercialized research funding; and detailing the nature, extent, and consequences of the present relationship among academe, government, and industry in the health sciences. The second section compares how the idea of conflicts of interest differs in biomedical research, legal work, and journalism. It includes a challenging look at the term itself and an argument for managed financial incentives. The final section describes and analyzes the existing regulatory regime, poses questions and directions for future self and external regulation, and provides perspectives from a third-party research company. This considered, balanced discussion will interest scholars of bioethics, public health, and health policy.

In a career that included tenures as president of Stony Brook University, director of Brookhaven National Laboratory, and science advisor to President George W. Bush, John Marburger (1941–2011) found himself on the front line of battles that pulled science ever deeper into the political arena. From nuclear power to global warming and stem cell research, science controversies, he discovered, are never just about science. Science Policy Up Close presents Marburger’s reflections on the challenges science administrators face in the twenty-first century. In each phase of public service Marburger came into contact with a new dimension of science policy. The Shoreham Commission exposed him to the problem of handling a volatile public controversy over nuclear power. The Superconducting Super Collider episode gave him insights into the collision between government requirements and scientists’ expectations and feelings of entitlement. The Directorship of Brookhaven taught him how to talk to the public about the risks of conducting high-energy physics and about large government research facilities. As Presidential Science Advisor he had to represent both the scientific community to the administration and the administration to the scientific community at a time when each side was highly suspicious of the other. What Marburger understood before most others was this: until the final quarter of the twentieth century, science had been largely protected from public scrutiny and government supervision. Today that is no longer true. Scientists and science policy makers can learn from Marburger what they must do now to improve their grip on their own work..